Skip to main content
Have a personal or library account? Click to login
Assessment of differential expression of oncogenes in adenocarcinoma of stomach with fluorescent labeling and simultaneous amplification of gene transcripts Cover

Assessment of differential expression of oncogenes in adenocarcinoma of stomach with fluorescent labeling and simultaneous amplification of gene transcripts

Open Access
|Jan 2008

References

  1. Ferlay J.. Lyon: IARC Press; 2001: 1 CD-ROM.
  2. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification.1965;: 31-49.
  3. Zheng L, Wang L, Ajani J, Xie K. Molecular basis of gastric cancer development and progression.2004;: 61-77.
  4. Kufe DW, Holland JF, Frei E, Abramson DH, Dang CT, DeAngelis LM, et al.6. Hamilton, Ont.: BC Decker; 2003.
  5. Barletta C, Scillato F, Sega FM, Mannella E. Genetic alteration in gastrointestinal cancer. A molecular and cytogenetic study.1993;: 2325-9.
  6. Tahara E. Genetic pathways of two types of gastric cancer.2004;: 327-49.
  7. Engelman JA, Zejnullahu K, Mitsudomi T, Song Y, Hyland C, Park JO, et al. MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.2007;: 1039-43.
  8. Smolen GA, Sordella R, Muir B, Mohapatra G, Barmettler A, Archibald H, et al. Amplification of MET may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752.2006;: 2316-21.
  9. Uen YH, Lin SR, Wu CH, Hsieh JS, Lu CY, Yu FJ, et al. Clinical significance of MUC1 and c-Met RT-PCR detection of circulating tumor cells in patients with gastric carcinoma.2006;: 55-61.
  10. Corso S, Comoglio PM, Giordano S. Cancer therapy: can the challenge be MET?2005;: 84-92.
  11. Felsher DW. Cancer revoked: oncogenes as therapeutic targets.2003;: 375-80.
  12. Kataoka H, Joh T, Kasugai K, Okayama N, Moriyama A, Asai K, et al. Expression of mRNA for heregulin and its receptor, ErbB-3 and ErbB-4, in human upper gastrointestinal mucosa.1998;: 553-64.
  13. Bachmair F, Huber C, Daxenbichler G. Quanititation of gene expression by means of HPLC analysis of RT-PCR products.1999;: 25-34.
  14. Huber CG. Micropellicular stationary phases for high-performance liquid chromatography of double-stranded DNA.1998;: 3-30.
  15. Heideman DA, Snijders PJ, Bloemena E, Meijer CJ, Offerhaus GJ, Meuwissen SG, et al. Absence of tpr-met and expression of c-met in human gastric mucosa and carcinoma.2001;: 428-35.
  16. Nakajima M, Sawada H, Yamada Y, Watanabe A, Tatsumi M, Yamashita J, et al. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.1999;: 1894-902.
  17. Rasola A, Fassetta M, De Bacco F, D'Alessandro L, Gramaglia D, Di Renzo MF, et al. A positive feedback loop between hepatocyte growth factor receptor and beta-catenin sustains colorectal cancer cell invasive growth.2007;: 1078-87.
  18. Bianco C, Adkins HB, Wechselberger C, Seno M, Normanno N, De Luca A, et al. Cripto-1 activates nodal- and ALK4-dependent and -independent signaling pathways in mammary epithelial Cells.2002;: 2586-97.
  19. Bianco C, Strizzi L, Mancino M, Rehman A, Hamada S, Watanabe K, et al. Identification of cripto-1 as a novel serologic marker for breast and colon cancer.2006;: 5158-64.
  20. Hamada S, Watanabe K, Hirota M, Bianco C, Strizzi L, Mancino M, et al. beta-Catenin/TCF/LEF regulate expression of the short form human Cripto-1.2007;: 240-4.
  21. Minchiotti G. Nodal-dependant Cripto signaling in ES cells: from stem cells to tumor biology.2005;: 5668-75.
  22. Haruma K, Ito M, Kohmoto K, Kamada T, Kitada Y, Yasui W, et al. Expression of cell cycle regulators and growth factor/receptor systems in gastric carcinoma in young adults: association with Helicobacter pylori infection.2000;: 185-90.
  23. Akama Y, Yasui W, Yokozaki H, Kuniyasu H, Kitahara K, Ishikawa T, et al. Frequent amplification of the cyclin E gene in human gastric carcinomas.1995;: 617-21.
  24. Tenderenda M. A study on the prognostic value of cyclins D1 and E expression levels in resectable gastric cancer and on some correlations between cyclins expression, histoclinical parameters and selected protein products of cell-cycle regulatory genes.2005;: 405-14.
  25. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H. Molecular-pathological prognostic factors of gastric cancer: a review.2005;: 86-94.
  26. Yu J, Miehlke S, Ebert MP, Szokodi D, Wehvnignh B, Malfertheiner P, et al. Expression of cyclin genes in human gastric cancer and in first degree relatives.2002;: 710-5.
  27. Breuleux M. Role of heregulin in human cancer.2007;: 2358-77.
  28. Kobayashi M, Iwamatsu A, Shinohara-Kanda A, Ihara S, Fukui Y. Activation of ErbB3-PI3-kinase pathway is correlated with malignant phenotypes of adenocarcinomas.2003;: 1294-301.
  29. Slesak B, Harlozinska A, Porebska I, Bojarowski T, Lapinska J, Rzeszutko M, et al. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.1998;: 2727-32.
DOI: https://doi.org/10.2478/v10019-007-0028-3 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 174 - 182
Published on: Jan 21, 2008
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2008 Uroš Rajčevic, Petra Hudler, Gordan Mijovski, Gregor Gorjanc, Georg Hoelzl, Stanislav Repše, Robert Juvan, Milena Kovač, Christian Huber, Radovan Komel, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons License.